These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12219014)

  • 1. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database.
    Moul JW; Wu H; Sun L; McLeod DG; Amling C; Lance R; Kusuda L; Donahue T; Foley J; Chung A; Sexton W; Soderdahl D; Rich NM
    Surgery; 2002 Aug; 132(2):213-9. PubMed ID: 12219014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national database.
    Moul JW; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Donahue T
    Urol Oncol; 2003; 21(6):447-55. PubMed ID: 14693271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system.
    Tarman GJ; Kane CJ; Moul JW; Thrasher JB; Foley JP; Wilhite D; Riffenburgh RH; Amling CL
    Urology; 2000 Dec; 56(6):1016-20. PubMed ID: 11113750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy?
    Carver BS; Bozeman CB; Venable DD; Eastham JA
    J Urol; 2004 Feb; 171(2 Pt 1):700-2. PubMed ID: 14713790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
    Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
    J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
    J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of extracapsular extension and positive margins in African American and white men.
    Paquette EL; Connelly RR; Sun L; Paquette LR; Moul JW
    Urol Oncol; 2003; 21(1):33-8. PubMed ID: 12684125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of race and adverse pathologic findings after radical prostatectomy.
    Freedland SJ; Dorey F; Aronson WJ
    Urology; 2000 Nov; 56(5):807-11. PubMed ID: 11068307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma.
    Paquette EL; Connelly RR; Sesterhenn IA; Zhang W; Sun L; Paquette LR; Greenspan R; McLeod DG; Moul JW
    Cancer; 2001 Nov; 92(10):2673-9. PubMed ID: 11745203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Amling CL; Dorey F; Kane CJ; Presti JC; Terris MK; Aronson WJ;
    Urology; 2002 Oct; 60(4):670-4. PubMed ID: 12385931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?
    Lam JS; Desai M; Mansukhani MM; Benson MC; Goluboff ET
    J Urol; 2003 Dec; 170(6 Pt 1):2288-91. PubMed ID: 14634398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.